bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Change in Receivables of $143274.0 for Q1 2026, up 181.66% YoY from $50868.4 in Q1 2025, and up 54.1% sequentially from $92972.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Change in Receivables across 5 years of filings, most recently posting $143274.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 181.66% year-over-year to $143274.0; the TTM figure through Mar 2026 stood at -$278508.0 (down 74.21% YoY), while the FY2025 annual figure was -$597242.0, down 282.35% from the prior year.
- Change in Receivables improved to $143274.0 in Q1 2026, from $92972.0 in the prior quarter.
- Over the last five years, Change in Receivables for BIAF reached as high as $472017.0 in Q2 2024 and fell as low as -$541875.0 in Q2 2025.
- The 5-year median for Change in Receivables is $956.0 (2022), against an average of -$25226.2.
- Annual changes were most pronounced in 2023 — Change in Receivables plunged 42949.02% — and 2024, when it jumped 57880.48%.
- A 5-year view of Change in Receivables shows it stood at $559.0 in 2022, then sank by 42949.02% to -$239526.0 in 2023, then increased by 21.53% to -$187964.0 in 2024, then surged by 149.46% to $92972.0 in 2025, then soared by 54.1% to $143274.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $143274.0, $92972.0, and $27121.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 121.07 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -12.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -65.11 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | 143,274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,274.00 |
| Mar 31, 2026 | 143,274.00 |
| Dec 31, 2025 | 92,972.00 |
| Dec 31, 2025 | 92,972.00 |
| Sep 30, 2025 | 27,121.00 |
| Sep 30, 2025 | 27,121.00 |
| Jun 30, 2025 | -541,875.00 |
| Jun 30, 2025 | -541,875.00 |
| Mar 31, 2025 | -175,460.00 |
| Mar 31, 2025 | -175,460.00 |
| Dec 31, 2024 | -187,964.00 |
| Dec 31, 2024 | -187,964.00 |
| Sep 30, 2024 | -268,458.00 |
| Sep 30, 2024 | -268,458.00 |
| Jun 30, 2024 | 472,017.00 |
| Jun 30, 2024 | 472,017.00 |
| Mar 31, 2024 | 311,935.00 |
| Mar 31, 2024 | 311,935.00 |
| Dec 31, 2023 | -239,526.00 |
| Dec 31, 2023 | -239,526.00 |